Kevin Hornsby

Full Report

Key Points

• Kevin Hornsby, a physician, was associated with two companies, Premier Men’s Medical Center, LLC, and Premier Men’s Health Florida, LLC, ordered to pay $1.7 million for deceptive marketing of erectile dysfunction treatments at an unlicensed medical clinic in Framingham, Massachusetts.

• The companies falsely advertised treatments as “FDA-approved” and misrepresented Hornsby’s qualifications, claiming he was a “board-certified urologist.”

• The settlement included a permanent injunction against Hornsby and the companies, prohibiting unlicensed medical practice and deceptive advertising.

• No direct consumer reviews or feedback specifically tied to Hornsby were found in the provided source or related searches, limiting insight into customer experiences.

• Hornsby’s involvement raises significant legal and reputational risks due to deceptive practices and regulatory violations.

Overview

Kevin Hornsby is a physician linked to Premier Men’s Medical Center, LLC, and Premier Men’s Health Florida, LLC, which operated an unlicensed medical clinic in Framingham, Massachusetts. These companies focused on marketing and providing treatments for erectile dysfunction and related men’s health issues. Hornsby was presented as a key medical figure in their operations, though the companies misrepresented his credentials, falsely claiming he was a board-certified urologist. The clinic’s activities came under scrutiny by the Massachusetts Attorney General’s Office, leading to a significant legal settlement in 2024.

Allegations and Concerns

• Deceptive Marketing Practices: The companies falsely advertised their erectile dysfunction treatments as “FDA-approved” and effective, misleading consumers about the safety and efficacy of the treatments.

• Misrepresentation of Credentials: Hornsby was promoted as a “board-certified urologist,” a claim found to be false, as he lacked such certification.

• Unlicensed Medical Practice: The clinic operated without proper licensing, violating Massachusetts state regulations for medical facilities.

• Legal Action: In 2024, a Suffolk Superior Court consent judgment ordered Hornsby and the companies to pay $1.7 million, including $1 million in civil penalties and $700,000 in restitution to affected consumers. A permanent injunction was issued, barring Hornsby and the companies from engaging in unlicensed medical practice or deceptive advertising.

Customer Feedback

No specific consumer reviews or testimonials directly tied to Kevin Hornsby or the Framingham clinic were identified in the provided source or related web and X searches. The lack of direct feedback may be due to the clinic’s closure following legal action or limited public documentation. However, the nature of the allegations suggests potential consumer harm, as patients were misled about treatment efficacy and Hornsby’s qualifications. Without direct quotes or reviews, it’s challenging to assess customer sentiment, but the deceptive practices likely eroded trust among patients.

Risk Considerations

• Financial Risks: The $1.7 million settlement imposes significant financial liability on Hornsby and the associated companies, potentially impacting their ability to operate or cover debts. Future fines or lawsuits could arise if similar practices are uncovered elsewhere.

• Reputational Risks: Hornsby’s association with deceptive marketing and misrepresentation of credentials severely damages his professional credibility. This could limit his ability to practice medicine or affiliate with reputable healthcare entities.

• Legal Risks: The permanent injunction restricts Hornsby’s ability to engage in medical practice without proper licensing, and any violation could lead to further legal consequences. Additional regulatory scrutiny from state or federal authorities is possible.

• Consumer Trust Risks: The misleading claims about FDA approval and Hornsby’s qualifications likely eroded patient trust, posing challenges for any future medical ventures he may pursue.

Business Relations and Associations

• Premier Men’s Medical Center, LLC, and Premier Men’s Health Florida, LLC: Hornsby was a central figure in these companies’ operations, though specific ownership or management details are unclear from the source. The companies were jointly responsible for the deceptive practices and faced the same legal penalties.

• No Other Named Associates: The source does not mention other individuals or entities directly involved with Hornsby or the clinic, limiting insight into broader partnerships.

• Regulatory Oversight: The Massachusetts Attorney General’s Office and the Suffolk Superior Court were key entities in addressing the violations, indicating significant regulatory involvement.

Legal and Financial Concerns

• Lawsuit and Settlement: In 2024, the Suffolk Superior Court issued a consent judgment against Hornsby and the two companies, mandating a $1.7 million payment ($1 million in penalties, $700,000 in restitution). This followed allegations of unlicensed practice and deceptive marketing.

• Permanent Injunction: The court barred Hornsby and the companies from operating unlicensed medical facilities or engaging in deceptive advertising, with strict compliance requirements.

• No Bankruptcy Records: No evidence of bankruptcy filings by Hornsby or the companies was found in the provided source or related searches.

• Potential Unpaid Debts: The significant financial penalty may strain the companies’ or Hornsby’s finances, though no specific unpaid debts were documented.

Risk Assessment Table

Kevin Hornsby’s involvement with Premier Men’s Medical Center, LLC, and Premier Men’s Health Florida, LLC, reflects serious professional and ethical lapses. The deceptive marketing of erectile dysfunction treatments and misrepresentation of Hornsby’s credentials as a “board-certified urologist” indicate a deliberate attempt to mislead vulnerable consumers seeking medical care. The $1.7 million settlement and permanent injunction underscore the severity of the violations, signaling significant legal and financial repercussions.

Individuals or entities considering associating with Hornsby should exercise extreme caution. Verify his current licensing status and any ongoing affiliations with medical practices. Patients should seek providers with transparent credentials and avoid clinics with a history of regulatory violations. Businesses or investors should avoid partnerships with Hornsby or similar entities until a track record of compliance and ethical conduct is established.